ExpressPoints: Personalizing Therapy With Factor VIII Prophylaxis in Hemophilia A

Download this summary slideset with essential expert insights on the clinical management of patients with hemophilia A.
Michael Callaghan, MD
Miguel A. Escobar, MD
Guy A. Young, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 252 KB
Released: November 5, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Takeda Pharmaceuticals USA, LLC

Related Content

Commentary from Michael Callaghan, MD, on individualizing hemophilia prophylaxis with extended half-life products and PK profiling tools, from CCO

Michael Callaghan, MD Released: November 20, 2020

Janet L. Kwiatkowski, MD, MSCE, on current and emerging therapies for beta-thalassemia in a commentary from Clinical Care Options (CCO)

Janet L. Kwiatkowski, MD, MSCE Released: November 12, 2020

Downloadable slides with expert analysis on managing CVD and other comorbidities in older patients with hemophilia A, from Clinical Care Options.

Miguel A. Escobar, MD Released: October 29, 2020

Downloadable slides with expert analysis of treating patients with hemophilia A with EHL Factor VIII therapy from Clinical Care Options.

Guy A. Young, MD Released: October 29, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue